Cargando…

Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial

OBJECTIVES: In clinical trials, adverse events are usually self-reported but may be adjudicated if serious or of particular interest. After adjudicating cardiovascular events for a 5-year calcium supplement trial, we observed discrepancies between self-reported and verified events. We systematically...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolland, Mark J, Barber, Alan, Doughty, Robert N, Grey, Andrew, Gamble, Greg, Reid, Ian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612743/
https://www.ncbi.nlm.nih.gov/pubmed/23512838
http://dx.doi.org/10.1136/bmjopen-2012-002334
_version_ 1782264676162207744
author Bolland, Mark J
Barber, Alan
Doughty, Robert N
Grey, Andrew
Gamble, Greg
Reid, Ian R
author_facet Bolland, Mark J
Barber, Alan
Doughty, Robert N
Grey, Andrew
Gamble, Greg
Reid, Ian R
author_sort Bolland, Mark J
collection PubMed
description OBJECTIVES: In clinical trials, adverse events are usually self-reported but may be adjudicated if serious or of particular interest. After adjudicating cardiovascular events for a 5-year calcium supplement trial, we observed discrepancies between self-reported and verified events. We systematically analysed those differences to assess their importance. DESIGN: Secondary analysis of adverse cardiovascular events in a 5-year, randomised, placebo-controlled trial of calcium supplementation (1 g calcium daily) in 1471 postmenopausal women (mean age 74 years). SETTING: Clinical research centre. METHODS: The participant's medical records were reviewed for all self-reported myocardial infarctions (MIs) or strokes, and the event independently adjudicated. Cause of death was obtained from hospital records or death certificates. To identify unreported events, the national hospital discharge database was searched and related hospital records were reviewed. RESULTS: 45 women reported 64 MIs, of which 33 (52%) were verified after adjudication. An additional 25 MIs were identified: 1 during adjudication of other events, 21 from the hospital discharge database, 3 from death certificates. 68 women reported 86 strokes of which 50 (58%) were verified. An additional 13 strokes were identified: 7 during adjudication of reported transient ischaemic attacks, 5 from the hospital discharge database, 1 from death certificates. Therefore, 43% of verified MIs and 21% of verified strokes were not reported to investigators. For non-adjudicated discharge codes, 10% of MIs and 22% of strokes were not verified after adjudication. Nineteen per cent of verified MIs and 27% of verified strokes were not identified in discharge coding or death certificates. Neither the event source nor the level of adjudication altered the relationship between treatment allocation and cardiovascular events. CONCLUSIONS: When adverse event accuracy is critical, researchers should consider adjudicating self-reported events and hospital discharge codes, and attempt to identify unreported events. TRIAL REGISTRATION: Australia New Zealand Clinical Trials registry: ACTRN 012605000242628.
format Online
Article
Text
id pubmed-3612743
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36127432013-07-08 Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial Bolland, Mark J Barber, Alan Doughty, Robert N Grey, Andrew Gamble, Greg Reid, Ian R BMJ Open Diabetes and Endocrinology OBJECTIVES: In clinical trials, adverse events are usually self-reported but may be adjudicated if serious or of particular interest. After adjudicating cardiovascular events for a 5-year calcium supplement trial, we observed discrepancies between self-reported and verified events. We systematically analysed those differences to assess their importance. DESIGN: Secondary analysis of adverse cardiovascular events in a 5-year, randomised, placebo-controlled trial of calcium supplementation (1 g calcium daily) in 1471 postmenopausal women (mean age 74 years). SETTING: Clinical research centre. METHODS: The participant's medical records were reviewed for all self-reported myocardial infarctions (MIs) or strokes, and the event independently adjudicated. Cause of death was obtained from hospital records or death certificates. To identify unreported events, the national hospital discharge database was searched and related hospital records were reviewed. RESULTS: 45 women reported 64 MIs, of which 33 (52%) were verified after adjudication. An additional 25 MIs were identified: 1 during adjudication of other events, 21 from the hospital discharge database, 3 from death certificates. 68 women reported 86 strokes of which 50 (58%) were verified. An additional 13 strokes were identified: 7 during adjudication of reported transient ischaemic attacks, 5 from the hospital discharge database, 1 from death certificates. Therefore, 43% of verified MIs and 21% of verified strokes were not reported to investigators. For non-adjudicated discharge codes, 10% of MIs and 22% of strokes were not verified after adjudication. Nineteen per cent of verified MIs and 27% of verified strokes were not identified in discharge coding or death certificates. Neither the event source nor the level of adjudication altered the relationship between treatment allocation and cardiovascular events. CONCLUSIONS: When adverse event accuracy is critical, researchers should consider adjudicating self-reported events and hospital discharge codes, and attempt to identify unreported events. TRIAL REGISTRATION: Australia New Zealand Clinical Trials registry: ACTRN 012605000242628. BMJ Publishing Group 2013-03-18 /pmc/articles/PMC3612743/ /pubmed/23512838 http://dx.doi.org/10.1136/bmjopen-2012-002334 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions this is an open-access article distributed under the terms of the creative commons attribution non-commercial license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. see: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Diabetes and Endocrinology
Bolland, Mark J
Barber, Alan
Doughty, Robert N
Grey, Andrew
Gamble, Greg
Reid, Ian R
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title_full Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title_fullStr Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title_full_unstemmed Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title_short Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
title_sort differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612743/
https://www.ncbi.nlm.nih.gov/pubmed/23512838
http://dx.doi.org/10.1136/bmjopen-2012-002334
work_keys_str_mv AT bollandmarkj differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial
AT barberalan differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial
AT doughtyrobertn differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial
AT greyandrew differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial
AT gamblegreg differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial
AT reidianr differencesbetweenselfreportedandverifiedadversecardiovasculareventsinarandomisedclinicaltrial